These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23385359)

  • 1. Parkinson's disease plasma biomarkers: an automated literature analysis followed by experimental validation.
    Alberio T; Bucci EM; Natale M; Bonino D; Di Giovanni M; Bottacchi E; Fasano M
    J Proteomics; 2013 Sep; 90():107-14. PubMed ID: 23385359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
    Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
    Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.
    DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG;
    Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease.
    Goldknopf IL; Sheta EA; Bryson J; Folsom B; Wilson C; Duty J; Yen AA; Appel SH
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1034-9. PubMed ID: 16516157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study.
    Ravina B; Eberly S; Oakes D; Lang AE; Dodelet V; Roos P; Harman J; Shoulson I; Schipper HM
    Biomark Med; 2015; 9(2):89-97. PubMed ID: 25689898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
    Teixeira Dos Santos MC; Bell R; da Costa AN
    Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease.
    Li YH; Wang J; Zheng XL; Zhang YL; Li X; Yu S; He X; Chan P
    Eur Neurol; 2011; 65(2):105-11. PubMed ID: 21273779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach.
    Chen HM; Lin CY; Wang V
    Clin Biochem; 2011 Apr; 44(5-6):377-85. PubMed ID: 21223953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
    Zhao H; Wang C; Zhao N; Li W; Yang Z; Liu X; Le W; Zhang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():101-108. PubMed ID: 29518718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease.
    Alberio T; Pippione AC; Zibetti M; Olgiati S; Cecconi D; Comi C; Lopiano L; Fasano M
    Sci Rep; 2012; 2():953. PubMed ID: 23233872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.
    Zhang X; Yin X; Yu H; Liu X; Yang F; Yao J; Jin H; Yang P
    Analyst; 2012 Jan; 137(2):490-5. PubMed ID: 22108571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?
    Moccia M; Picillo M; Erro R; Vitale C; Longo K; Amboni M; Santangelo G; Spina E; De Rosa A; De Michele G; Santoro L; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2014 Jul; 20(7):772-5. PubMed ID: 24725754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
    Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
    Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific splice variants are associated with Parkinson's disease.
    Santiago JA; Scherzer CR; ; Potashkin JA
    Mov Disord; 2013 Oct; 28(12):1724-7. PubMed ID: 24108702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted discovery and validation of plasma biomarkers of Parkinson's disease.
    Pan C; Zhou Y; Dator R; Ginghina C; Zhao Y; Movius J; Peskind E; Zabetian CP; Quinn J; Galasko D; Stewart T; Shi M; Zhang J
    J Proteome Res; 2014 Nov; 13(11):4535-45. PubMed ID: 24853996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Found in transcription: accurate Parkinson's disease classification in peripheral blood.
    Karlsson MK; Sharma P; Aasly J; Toft M; Skogar O; Sæbø S; Lönneborg A
    J Parkinsons Dis; 2013; 3(1):19-29. PubMed ID: 23938308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease.
    Argüelles S; Venero JL; García-Rodriguez S; Tomas-Camardiel M; Ayala A; Cano J; Machado A
    Neurochem Int; 2010 Oct; 57(3):227-34. PubMed ID: 20553985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of serum vitamin K2 levels with Parkinson's disease: from basic case-control study to big data mining analysis.
    Yu YX; Yu XD; Cheng QZ; Tang L; Shen MQ
    Aging (Albany NY); 2020 Aug; 12(16):16410-16419. PubMed ID: 32862152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms.
    Tong Q; Zhang L; Yuan Y; Jiang S; Zhang R; Xu Q; Ding J; Li D; Zhou X; Zhang K
    Parkinsonism Relat Disord; 2015 Aug; 21(8):882-7. PubMed ID: 26028271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.